SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ATIS is on the move!
ATIS 0.1000-47.4%Apr 14 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WWS who wrote (1209)12/9/1997 8:28:00 PM
From: David S.  Read Replies (1) of 2205
 
No, I don't value development stage biotechs based on trailing revenue. The market caps of the 2 stocks I mentioned are vastly different, yet the companies are approaching the same market in different ways. the management of atis crows about being able to grow any body part (reminds me of a great flick, Frankenhooker), but anyway in the meantime since they've been public they've been touted by many analysts and brokerage firms, yet all they have to show for it are drawers of foreskins hermetically sealed in ziplock bags. Where is the greater upside - in the stock with the .5billion cap or the one with a fifth of that which is approaching the market with equally valid technology?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext